
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
AstraZeneca
Market Cap: UK£181.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£117.08
7D
-1.2%
1Y
1.1%
Chugai Pharmaceutical
Market Cap: JP¥11.8t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,175.00
7D
6.1%
1Y
17.0%
Orion Oyj
Market Cap: €11.0b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€79.90
7D
-2.1%
1Y
18.8%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥53.7b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥119.36
7D
7.8%
1Y
32.6%
Xiamen Amoytop Biotech
Market Cap: CN¥25.1b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥61.43
7D
12.6%
1Y
-28.2%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€58.15
7D
-0.8%
1Y
3.7%
PharmaResearch
Market Cap: ₩4.4t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩425,500.00
7D
7.9%
1Y
-37.8%